MergerApr 15, 2026, 04:06 PM
Lisata Therapeutics: Kuva Labs Delays Tender Offer for Merger
AI Summary
Lisata Therapeutics announced that the tender offer by Kuva Labs Inc., part of their previously disclosed merger agreement, has not yet commenced. The commencement date was previously extended from April 3, 2026, to April 13, 2026. Kuva Labs is reportedly seeking alternative financing on more favorable terms to fund the tender offer, and Lisata is in discussions with them regarding the financing and timing. There is no assurance as to when, or if, the tender offer will begin.
Key Highlights
- Tender offer by Kuva Labs for Lisata shares has not yet commenced.
- Original tender offer commencement date was extended from April 3 to April 13, 2026.
- Kuva Labs is seeking alternative financing for the tender offer.
- Lisata is in discussions with Parent regarding financing and timing.
- No assurance on when or if the tender offer will commence.